XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Net product revenue $ 41,504 $ 1,496 $ 68,682 $ 1,496
Cost of products sold 2,788 36 4,310 36
Gross profit 38,716 1,460 64,372 1,460
Operating expenses:        
Research and development expenses 4,051 4,223 7,119 8,053
Selling, general and administrative expenses 47,406 46,778 96,029 71,246
Total operating expense 51,457 51,001 103,148 79,299
Operating loss (12,741) (49,541) (38,776) (77,839)
Investment and other income, net 1,126 623 2,504 816
Interest expense (2,716) (2,295) (5,308) (5,554)
Loss on extinguishment of debt 0 (13,129) 0 (13,129)
Loss before income taxes (14,331) (64,342) (41,580) (95,706)
Income tax (benefit) provision (509) 90 (416) (490)
Net loss $ (13,822) $ (64,432) $ (41,164) $ (95,216)
Net loss per share - basic (in dollars per share) $ (0.14) $ (0.83) $ (0.44) $ (1.35)
Net loss per share - diluted (in dollars per share) $ (0.14) $ (0.83) $ (0.44) $ (1.35)
Weighted average number of shares outstanding - basic (in shares) 96,151 77,246 93,922 70,603
Weighted average number of shares outstanding - diluted (in shares) 96,151 77,246 93,922 70,603